Koers Jilin Aodong Pharmaceutical Group Co., Ltd.
Aandelen
000623
CNE000000719
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,46 CNY | +0,70% | -3,41% | -4,49% |
Omzet 2023 * | 3,45 mld. 478 mln. 443 mln. | Omzet 2024 * | 4,12 mld. 571 mln. 529 mln. | Marktkapitalisatie | 17,38 mld. 2,41 mld. 2,23 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | 2,06 mld. 285 mln. 264 mln. | Nettowinst (verlies) 2024 * | 2,33 mld. 323 mln. 299 mln. | EV/omzet 2023 * | 5,04 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 4,22 x |
K/w-verhouding 2023 * |
8,17
x | K/w-verhouding 2024 * |
7,21
x | Werknemers | 5.399 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 71,21% |
1 dag | +0,70% | ||
1 week | -3,41% | ||
Lopende maand | -4,74% | ||
1 maand | -3,34% | ||
3 maanden | -4,68% | ||
6 maanden | -16,22% | ||
Lopend jaar | -4,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 01-01-98 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 01-05-04 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 01-07-99 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 01-02-93 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 01-01-98 |
Yong Feng Chen
CHM | Chairman | 57 | 01-10-00 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
29-03-24 | 14,46 | +0,70% | 8 539 233 |
28-03-24 | 14,36 | +0,21% | 9 532 032 |
27-03-24 | 14,33 | -0,90% | 8 954 162 |
26-03-24 | 14,46 | +0,49% | 8 287 771 |
25-03-24 | 14,39 | -1,44% | 12 854 440 |
slotkoers Shenzhen S.E., 29 maart 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,49% | 2,39 mld. | |
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+2,95% | 212 mld. | |
+0,74% | 209 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. |